Thalidomide may impede cell migration in primates by down-regulating integrin β-chains: potential therapeutic utility in solid malignancies, proliferative retinopathy, inflammatory disorders, neointimal hyperplasia, and osteoporosis
References (108)
- et al.
Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions
J Am Acad Dermatol
(1982) - et al.
Recurrent aphthous stomatitis of the Behcet's type: successful treatment with thalidomide
Oral Surg Oral Med Oral Pathol
(1987) - et al.
Thalidomide for therapy of graft-versus-host disease following allogeneic bone marrow transplantation
Biomed Pharmacother
(1989) - et al.
Thalidomide for systemic lupus erythematosus
Lancet
(1992) - et al.
Thalidomide: treatment of choice for aphthous ulcers in patients seropositive for human immunodeficiency virus
J Am Acad Dermatol
(1993) - et al.
Thalidomide and the immune system. 2: Changes in receptors on blood cells of a healthy volunteer
Life Sci
(1992) - et al.
Thalidomide and the immune system. 3: Simultaneous up- and downregulation of different integrin receptors on human white blood cells
Life Sci
(1994) Integrins: versatility, modulation, and signaling in cell adhesion
Cell
(1992)- et al.
Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons
Cell
(1992) An antibody to a receptor for fibronectin and laminin perturbs cranial neural crest development in vivo
Devel Biol
(1986)
The 140-kDa fibronectin receptor complex is required for mesodermal cell adhesion during gastrulation in the amphibian Pleurodeles waldii
Devel Biol
(1988)
Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist Gpen-GRGDSPCA
J Vasc Surg
(1994)
Tumor interactions with the vasculature: angiogenesis and tumor metastasis
Biochim Biophys Acta
(1990)
Angiogenesis
J Biol Chem
(1992)
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Cell
(1994)
Expression and modulation of the vitronectin receptor on human dermal microvascular endothelial cells
J Invest Dermatol
(1992)
Anchorage dependence, integrins, and apoptosis
Cell
(1994)
Basic FGF and TGF-(3 differentially modulate integrin expression of human microvascular endothelial cells
Exp Cell Res
(1992)
Current status of vascular grafts
Surg Clin North Am
(1982)
Recognition of osteopontin and related peptides by an βvβ3 integrin stimulates immediate cell signals in osteoclasts
J Biol Chem
(1991)
RGD-directed attachment of isolated rat osteoclasts to osteopontin, bone sialoprotein, and fibronectin
Exp Cell Research
(1992)
Eicosapentaenoic acid reduces the invasive and metastatic activities of malignant tumor cells
Biochem Biophys Res Commun
(1989)
Effects of fatty acids on invasion through reconstituted basement membrane (‘Matrigal’) by a human breast cancer cell line
Cancer Lett
(1993)
Fish oil may impede tumour angiogenesis and invasiveness by down-regulating protein kinase C and modulating eicosanoid production
Med Hypotheses
(1996)
Inhibitory effect of fish oil n-3 poly-unsaturated fatty acids on the expression of endothelial cell adhesion molecules
Biochem Biophys Res Commun
(1996)
Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia
Nutrition
(1996)
The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer
Nutrition
(1996)
Eicospentaenoic acid inhibits bone loss due to ovariectomy in rats
Prost Leuk Essent Fatty Acids
(1994)
The protective role of eicosapentaenoic acid [EPA] in the pathogenesis of nephrolithiasis
J Urol
(1991)
Does fish oil benefit stone formers?
J Urol
(1993)
Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis
Biochim Biophys Acta
(1988)
Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade
Cell
(1986)
Characterization of the cellular binding site for the urokinase-type plasminogen activator
J Biol Chem
(1989)
Antibodies to plasminogen activator inhibit human tumor metastasis
Cell
(1983)
Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo
Cell
(1988)
Thalidomide in the treatment of lepra reactions
Clin Pharmacol Ther
(1965)
Kellersberger Memorial lecture 1979: immunosuppressive/anti-inflammatory thalidomide analogues
Ethiop Med J
(1980)
Thalidomide for autuimmune disease
Med Hypotheses
(1983)
Thalidomide therapy for inflammatory dermatoses
Int J Dermatol
(1984)
La thalidomide dans le traitement du lupus érythémateux chronique
Ann Dermatol Venereol
(1980)
Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosis
Br J Dermatol
(1983)
Treatment of refractory rheumatoid arthritis — the thalidomide experience
J Rheumatol
(1989)
Combination thalidomide and cyclosporine for cardiac allograft rejection: Comparison with combination methylprednisolone and cyclosporine
Transplantation
(1990)
Thalidomide treatment for chronic graft-versus-host disease
Br J Haematol
(1991)
Thalidomide to treat esophageal ulcer in AIDS
N Engl J Med
(1992)
Thalidomide for the treatment of chronic graft-versus-host disease
N Engl J Med
(1992)
Thalidomide is an inhibitor of angiogenesis
Thalidomide derivatives and the immune system. I: Changes in the pattern of integrin receptors and other surface markers on T lymphocyte subpopulations of marmoset blood
Arch Toxicol
(1993)
Thalidomide and the immune system. 4: Down-regulation of the CD26 receptor, probably involved in the binding of HIV components to T cells in primates
Life Sci
(1995)
Adhesion receptors of the immune system
Nature
(1990)
Cited by (0)
Copyright © 1997 Published by Elsevier Ltd.